Blood Eosinophilia and Its Stability in Hospitalized COPD Exacerbations are Associated with Lower Risk of All-Cause Mortality

References

• SteerJ, GibsonGJ, BourkeSC. Predicting outcomes following hospitalization for acute exacerbations of COPD. QJM. 2010;103(11):817–829. doi:10.1093/qjmed/hcq12620660633
   PubMed Web of Science ®Google Scholar
• SinghD, KolsumU, BrightlingCE, et al. Eosinophilic inflammation in COPD: prevalence and clinical characteristics. Eur Respir J. 2014;44(6):1697–1700. doi:10.1183/09031936.0016241425323230
   PubMed Web of Science ®Google Scholar
• NegewoNA, McDonaldVM, BainesKJ, et al. Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:1495–1504. doi:10.2147/COPD.S10033827445469
   PubMed Web of Science ®Google Scholar
• Serafino-AgrusaL, ScichiloneN, SpataforaM, BattagliaS. Blood eosinophils and treatment response in hospitalized exacerbations of chronic obstructive pulmonary disease: a case-control study. Pulm Pharmacol Ther. 2016;37:89–94. doi:10.1016/j.pupt.2016.03.00426996272
   PubMed Web of Science ®Google Scholar
• SaltürkC, KarakurtZ, AdiguzelN, KarginF, SariR, CelikME. Does eosinophilic COPD exacerbation have a better patient outcome than non-eosinophilic in the intensive care unit? Int J Chron Obstruct Pulmon Dis. 2015;10:1837–1846. doi:10.2147/COPD.S8805826392758
   PubMed Web of Science ®Google Scholar
• CouillardS, LarivéeP, CourteauJ, VanasseA. Eosinophils in COPD exacerbations are associated with increased readmissions. Chest. 2017;151(2):366–373. doi:10.1016/j.chest.2016.10.00327746201
   PubMed Web of Science ®Google Scholar
• BafadhelM, GreeningNJ, Harvey-DunstanTC, et al. Blood eosinophils and outcomes in severe hospitalized exacerbations of COPD. Chest. 2016;150(2):320–328. doi:10.1016/j.chest.2016.01.02626851799
   PubMed Web of Science ®Google Scholar
• BarnesNC, SharmaR, LettisS, CalverleyPM. Blood eosinophils as a marker of response to inhaled corticosteroids in COPD. Eur Respir J. 2016;47(5):1374–1382. doi:10.1183/13993003.01370-201526917606
   PubMed Web of Science ®Google Scholar
• BafadhelM, McKennaS, TerryS, et al. Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial. Am J Respir Crit Care Med. 2012;186(1):48–55. doi:10.1164/rccm.201108-1553OC22447964
   PubMed Web of Science ®Google Scholar
• BafadhelM, DaviesL, CalverleyPM, AaronSD, BrightlingCE, PavordID. Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis. Eur Respir J. 2014;44(3):789–791. doi:10.1183/09031936.0006261424925917
   PubMed Web of Science ®Google Scholar
• OhYM, LeeKS, HongY, et al. Blood eosinophil count as a prognostic biomarker in COPD. Int J Chron Obstruct Pulmon Dis. 2018;13:3589–3596. doi:10.2147/COPD.S17973430464441
   PubMed Web of Science ®Google Scholar
• MendyA, FornoE, NiyonsengaT, GasanaJ. Blood biomarkers as predictors of long-term mortality in COPD. Clin Respir J. 2018;12(5):1891–1899. doi:10.1111/crj.1275229227024
   PubMed Web of Science ®Google Scholar
• LiQ, LarivéeP, CourteauJ, et al. Greater eosinophil counts at first COPD hospitalization are associated with more readmissions and fewer deaths. Int J Chron Obstruct Pulmon Dis. 2019;14:331–341. doi:10.2147/COPD.S18737530787603
   PubMed Web of Science ®Google Scholar
• ZysmanM, DesleeG, CaillaudD, et al. Relationship between blood eosinophils, clinical characteristics, and mortality in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:1819–1824. doi:10.2147/COPD.S12978728694695
   PubMed Web of Science ®Google Scholar
• CasanovaC, CelliBR, de-TorresJP, et al. Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD. Eur Respir J. 2017;50(5):1701162. doi:10.1183/13993003.01162-201729167301
   PubMed Web of Science ®Google Scholar
• GreulichT, MagerS, LuckeT, et al. Longitudinal stability of blood eosinophil count strata in the COPD COSYCONET cohort. Int J Chron Obstruct Pulmon Dis. 2018;13:2999–3002. doi:10.2147/COPD.S16590930319247
   PubMed Web of Science ®Google Scholar
• OshagbemiOA, BurdenAM, BraekenDCW, et al. Stability of blood eosinophils in patients with chronic obstructive pulmonary disease and in control subjects, and the impact of sex, age, smoking, and baseline counts. Am J Respir Crit Care Med. 2017;195(10):1402–1404. doi:10.1164/rccm.201701-0009LE28165763
   PubMed Web of Science ®Google Scholar
• ShinSH, ParkHY, KangD, et al. Serial blood eosinophils and clinical outcome in patients with chronic obstructive pulmonary disease. Respir Res. 2018;19(1):134. doi:10.1186/s12931-018-0840-x30001715
   PubMed Web of Science ®Google Scholar
• TuratoG, SemenzatoU, BazzanE, et al. Blood eosinophilia neither reflects tissue eosinophils nor worsens clinical outcomes in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2018;197(9):1216–1219. doi:10.1164/rccm.201708-1684LE29035097
   PubMed Web of Science ®Google Scholar
• SchumannDM, TammM, KostikasK, StolzD. Stability of the blood eosinophilic phenotype in stable and exacerbated COPD. Chest. 2019;156(3):456–465. doi:10.1016/j.chest.2019.04.01231047957
   PubMed Web of Science ®Google Scholar
• VogelmeierCF, CrinerGJ, MartinezFJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. Gold executive summary. Am J Respir Crit Care Med. 2017;195(5):557–582. doi:10.1164/rccm.201701-0218PP28128970
   PubMed Web of Science ®Google Scholar
• KimVL, CoombsNA, StaplesKJ, et al. Impact and associations of eosinophilic inflammation in COPD: analysis of the AERIS cohort. Eur Respir J. 2017;50(4):1700853. doi:10.1183/13993003.00853-201729025891
   PubMed Web of Science ®Google Scholar
• CharlsonME, PompeiP, AlesKL, MacKenzieCR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. doi:10.1016/0021-9681(87)90171-83558716
   PubMedGoogle Scholar
• PavordID, LettisS, AnzuetoA, BarnesN. Blood eosinophil count and pneumonia risk in patients with chronic obstructive pulmonary disease: a patient-level meta-analysis. Lancet Respir Med. 2016;4(9):731–741. doi:10.1016/S2213-2600(16)30148-527460163
   PubMed Web of Science ®Google Scholar
• WedzichaJA. Eosinophils as biomarkers of chronic obstructive pulmonary disease exacerbation risk. maybe just for some? Am J Respir Crit Care Med. 2016;193(9):937–938. doi:10.1164/rccm.201601-0015ED27128699
   PubMed Web of Science ®Google Scholar
• SouthworthT, BeechG, FodenP, KolsumU, SinghD. The reproducibility of COPD blood eosinophil counts. Eur Respir J. 2018;52(1):1800427. doi:10.1183/13993003.00427-201829724922
   PubMed Web of Science ®Google Scholar
• DiSantostefanoRL, HindsD, LeHV, BarnesNC. Relationship between blood eosinophils and clinical characteristics in a cross-sectional study of a US population-based COPD cohort. Respir Med. 2016;112:88–96. doi:10.1016/j.rmed.2016.01.01326872700
   PubMed Web of Science ®Google Scholar